Ahmedabad: Bioeq AG, a Swiss biopharmaceutical company, and Zydus Lifesciences, a life-sciences company with an international presence, have announced that its wholly owned subsidiary, ...
Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.
The most-read ophthalmology biosimilar stories of 2025 included FDA approvals and real-world data. The continued expansion of ...
EMA committee recommends marketing approval for Lupin’s biosimilar ranibizumab: Our Bureau, Mumbai Wednesday, December 17, 2025, 14:40 Hrs [IST] Global pharma major Lupin Limite ...
Emcure Pharmaceuticals has informed the exchanges that the United States Food and Drug Administration (USFDA) has issued a No ...
Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...
Microvascular endothelial dysfunction is an early or inductive event that occurs in the development of cardiovascular diseases and associated organ damage. The endothelium is composed of a single ...
Vascular inflammatory diseases, including atherosclerosis, are associated with an imbalance between pro-inflammatory and anti-inflammatory pathways. Cardiovascular diseases caused by atherosclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback